Compare AGYS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGYS | LGND |
|---|---|---|
| Founded | 1963 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | N/A | 1992 |
| Metric | AGYS | LGND |
|---|---|---|
| Price | $87.92 | $186.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $135.00 | ★ $243.50 |
| AVG Volume (30 Days) | ★ 423.3K | 251.0K |
| Earning Date | 01-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.51 | 0.76 |
| EPS | 1.07 | ★ 2.49 |
| Revenue | ★ $310,638,000.00 | $251,233,000.00 |
| Revenue This Year | $17.48 | $47.71 |
| Revenue Next Year | $14.68 | $9.77 |
| P/E Ratio | $80.42 | ★ $75.06 |
| Revenue Growth | 17.86 | ★ 64.83 |
| 52 Week Low | $63.71 | $93.58 |
| 52 Week High | $145.25 | $212.49 |
| Indicator | AGYS | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 35.24 | 40.13 |
| Support Level | $80.73 | $180.47 |
| Resistance Level | $89.80 | $202.79 |
| Average True Range (ATR) | 5.13 | 7.39 |
| MACD | -0.40 | -1.25 |
| Stochastic Oscillator | 21.77 | 20.42 |
Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.